_id
69147aa4ccc777a4e85d8ffa
Ticker
MNMD
Name
Mind Medicine Inc
Exchange
NASDAQ
Address
One World Trade Center, New York, NY, United States, 10007
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.mindmed.co
Description
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Last Close
12.38
Volume
1045206
Current Price
12.95
Change
4.6042003231017645
Last Updated
2025-12-02T11:59:48.407Z
Image
data:image/webp;base64,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
Ipo Date
2020-03-03T00:00:00.000Z
Market Cap
1191907328
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.64
Sentiment Sources
2
Rating
4.6364
Target Price
25.6364
Strong Buy
7
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
45669000
Operating Income
-45669000
Interest Expense
1274000
Pretax Income
-67265000
Net Income
-67265000
Eps
-0.7831937576063466
Dividends Per Share
-
Shares Outstanding
97219193
Income Tax Expense
-
EBITDA
-65984250
Operating Margin
-
Total Other Income Expense Net
-21596000
Cash
19959000
Short Term Investments
189111000
Receivables
-
Inventories
-
Total Current Assets
215848000
Property Plant Equipment
-
Total Assets
236916000
Payables
8113000
Short Term Debt
-
Long Term Debt
40385000
Total Liabilities
106320000
Equity
130596000
Depreciation
0
Change In Working Capital
8096000
Cash From Operations
-29567000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
749000
Net Change In Cash
-13433000
PE
-
PB
8.516473951728996
ROE
-51.50617170510582
ROA
-28.391919498894126
FCF
-29567000
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
45669000
Quarters > 0 > income Statement > operating Income
-45669000
Quarters > 0 > income Statement > interest Expense
1274000
Quarters > 0 > income Statement > pretax Income
-67265000
Quarters > 0 > income Statement > net Income
-67265000
Quarters > 0 > income Statement > eps
-0.7831937576063466
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
85885516
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-65984250
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-21596000
Quarters > 0 > balance Sheet > cash
19959000
Quarters > 0 > balance Sheet > short Term Investments
189111000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
215848000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
236916000
Quarters > 0 > balance Sheet > payables
8113000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
40385000
Quarters > 0 > balance Sheet > total Liabilities
106320000
Quarters > 0 > balance Sheet > equity
130596000
Quarters > 0 > cash Flow > net Income
-67265000
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
8096000
Quarters > 0 > cash Flow > cash From Operations
-29567000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
749000
Quarters > 0 > cash Flow > net Change In Cash
-13433000
Quarters > 0 > ratios > PE
-0.7831937576063466
Quarters > 0 > ratios > PB
8.516473951728996
Quarters > 0 > ratios > ROE
-51.50617170510582
Quarters > 0 > ratios > ROA
-28.391919498894126
Quarters > 0 > ratios > FCF
-29567000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
40903000
Quarters > 1 > income Statement > operating Income
-40903000
Quarters > 1 > income Statement > interest Expense
2338000
Quarters > 1 > income Statement > pretax Income
-42744000
Quarters > 1 > income Statement > net Income
-42744000
Quarters > 1 > income Statement > eps
-0.5008220668970287
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
85347677
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-40406000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1841000
Quarters > 1 > balance Sheet > cash
33392000
Quarters > 1 > balance Sheet > short Term Investments
149601000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
189136000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
265091000
Quarters > 1 > balance Sheet > payables
4216000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
41191000
Quarters > 1 > balance Sheet > total Liabilities
79691000
Quarters > 1 > balance Sheet > equity
185400000
Quarters > 1 > cash Flow > net Income
-42744000
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
8089000
Quarters > 1 > cash Flow > cash From Operations
-29599000
Quarters > 1 > cash Flow > capital Expenditures
4.28
Quarters > 1 > cash Flow > cash From Investing
-39538000
Quarters > 1 > cash Flow > cash From Financing
19650000
Quarters > 1 > cash Flow > net Change In Cash
-49462000
Quarters > 1 > ratios > PE
-0.5008220668970287
Quarters > 1 > ratios > PB
5.961447773193095
Quarters > 1 > ratios > ROE
-23.055016181229774
Quarters > 1 > ratios > ROA
-16.124274305804423
Quarters > 1 > ratios > FCF
-29599004.28
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
32159000
Quarters > 2 > income Statement > operating Income
-32159000
Quarters > 2 > income Statement > interest Expense
602000
Quarters > 2 > income Statement > pretax Income
-23348000
Quarters > 2 > income Statement > net Income
-23348000
Quarters > 2 > income Statement > eps
-0.26808598376825943
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
87091461
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-22746000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
8811000
Quarters > 2 > balance Sheet > cash
82854000
Quarters > 2 > balance Sheet > short Term Investments
129587000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
221700000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
275323000
Quarters > 2 > balance Sheet > payables
2268000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
22036000
Quarters > 2 > balance Sheet > total Liabilities
52517000
Quarters > 2 > balance Sheet > equity
222806000
Quarters > 2 > cash Flow > net Income
-23348000
Quarters > 2 > cash Flow > depreciation
0
Quarters > 2 > cash Flow > change In Working Capital
-2461000
Quarters > 2 > cash Flow > cash From Operations
-29419000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-162458000
Quarters > 2 > cash Flow > cash From Financing
1002000
Quarters > 2 > cash Flow > net Change In Cash
-190887000
Quarters > 2 > ratios > PE
-0.26808598376825943
Quarters > 2 > ratios > PB
5.061957128398697
Quarters > 2 > ratios > ROE
-10.479071479224078
Quarters > 2 > ratios > ROA
-8.48022141266803
Quarters > 2 > ratios > FCF
-29419000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
32462000
Quarters > 3 > income Statement > operating Income
-32462000
Quarters > 3 > income Statement > interest Expense
656000
Quarters > 3 > income Statement > pretax Income
-34741000
Quarters > 3 > income Statement > net Income
-34741000
Quarters > 3 > income Statement > eps
-0.4139184101415432
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
83932000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-34085000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-2279000
Quarters > 3 > balance Sheet > cash
273741000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
281620000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
302151000
Quarters > 3 > balance Sheet > payables
2010000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
21854000
Quarters > 3 > balance Sheet > total Liabilities
60703000
Quarters > 3 > balance Sheet > equity
241448000
Quarters > 3 > cash Flow > net Income
-34741000
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
-225000
Quarters > 3 > cash Flow > cash From Operations
-25351000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
2.39
Quarters > 3 > cash Flow > cash From Financing
3807000
Quarters > 3 > cash Flow > net Change In Cash
-21543000
Quarters > 3 > ratios > PE
-0.4139184101415432
Quarters > 3 > ratios > PB
4.501670753122825
Quarters > 3 > ratios > ROE
-14.388605414002187
Quarters > 3 > ratios > ROA
-11.497893437387265
Quarters > 3 > ratios > FCF
-25351000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
527000
Annuals > 0 > income Statement > gross Profit
-527000
Annuals > 0 > income Statement > operating Expenses
103389000
Annuals > 0 > income Statement > operating Income
-103916000
Annuals > 0 > income Statement > interest Expense
2283000
Annuals > 0 > income Statement > pretax Income
-108679000
Annuals > 0 > income Statement > net Income
-108679000
Annuals > 0 > income Statement > eps
-0.15423971524713637
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
704611000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-105869000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-4763000
Annuals > 0 > balance Sheet > cash
273741000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
281620000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
302151000
Annuals > 0 > balance Sheet > payables
2010000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
21854000
Annuals > 0 > balance Sheet > total Liabilities
60703000
Annuals > 0 > balance Sheet > equity
241448000
Annuals > 0 > cash Flow > net Income
-108679000
Annuals > 0 > cash Flow > depreciation
527000
Annuals > 0 > cash Flow > change In Working Capital
-3344000
Annuals > 0 > cash Flow > cash From Operations
-79129000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
253196000
Annuals > 0 > cash Flow > net Change In Cash
174037000
Annuals > 0 > ratios > PE
-0.15423971524713637
Annuals > 0 > ratios > PB
35.77801787548458
Annuals > 0 > ratios > ROE
-45.01134819919817
Annuals > 0 > ratios > ROA
-35.968439621248976
Annuals > 0 > ratios > FCF
-79129000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3162000
Annuals > 1 > income Statement > gross Profit
-3162000
Annuals > 1 > income Statement > operating Expenses
90704000
Annuals > 1 > income Statement > operating Income
-93866000
Annuals > 1 > income Statement > interest Expense
920000
Annuals > 1 > income Statement > pretax Income
-95732000
Annuals > 1 > income Statement > net Income
-95732000
Annuals > 1 > income Statement > eps
-2.4447984570995738
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
39157420
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-92570000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1866000
Annuals > 1 > balance Sheet > cash
99704000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
103872000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
124541000
Annuals > 1 > balance Sheet > payables
4136000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
14129000
Annuals > 1 > balance Sheet > total Liabilities
46407000
Annuals > 1 > balance Sheet > equity
78134000
Annuals > 1 > cash Flow > net Income
-95732000
Annuals > 1 > cash Flow > depreciation
3162000
Annuals > 1 > cash Flow > change In Working Capital
6281000
Annuals > 1 > cash Flow > cash From Operations
-64365000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
21848000
Annuals > 1 > cash Flow > net Change In Cash
-42438000
Annuals > 1 > ratios > PE
-2.4447984570995738
Annuals > 1 > ratios > PB
6.144187795325978
Annuals > 1 > ratios > ROE
-122.52284536821358
Annuals > 1 > ratios > ROA
-76.86785877743073
Annuals > 1 > ratios > FCF
-64365000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
3223000
Annuals > 2 > income Statement > gross Profit
-3223000
Annuals > 2 > income Statement > operating Expenses
66331000
Annuals > 2 > income Statement > operating Income
-66331000
Annuals > 2 > income Statement > interest Expense
1495000
Annuals > 2 > income Statement > pretax Income
-56796000
Annuals > 2 > income Statement > net Income
-56796000
Annuals > 2 > income Statement > eps
-1.8405920149689559
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
30857463
Annuals > 2 > income Statement > income Tax Expense
-9535000
Annuals > 2 > income Statement > EBITDA
-63151000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
9535000
Annuals > 2 > balance Sheet > cash
142142000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
146055000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
169993000
Annuals > 2 > balance Sheet > payables
2111000
Annuals > 2 > balance Sheet > short Term Debt
72000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
19076000
Annuals > 2 > balance Sheet > equity
150917000
Annuals > 2 > cash Flow > net Income
-56796000
Annuals > 2 > cash Flow > depreciation
3180000
Annuals > 2 > cash Flow > change In Working Capital
-3782000
Annuals > 2 > cash Flow > cash From Operations
-50139000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
59051000
Annuals > 2 > cash Flow > net Change In Cash
8603000
Annuals > 2 > ratios > PE
-1.8405920149689559
Annuals > 2 > ratios > PB
2.506758657937807
Annuals > 2 > ratios > ROE
-37.633931233724496
Annuals > 2 > ratios > ROA
-33.41078750301483
Annuals > 2 > ratios > FCF
-50139000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
2616000
Annuals > 3 > income Statement > gross Profit
-2616000
Annuals > 3 > income Statement > operating Expenses
93854000
Annuals > 3 > income Statement > operating Income
-93854000
Annuals > 3 > income Statement > interest Expense
359000
Annuals > 3 > income Statement > pretax Income
-94193000
Annuals > 3 > income Statement > net Income
-93036000
Annuals > 3 > income Statement > eps
-3.3983167600434276
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
27377083
Annuals > 3 > income Statement > income Tax Expense
-1157000
Annuals > 3 > income Statement > EBITDA
-91238000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-339000
Annuals > 3 > balance Sheet > cash
133539000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
137215000
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
164002000
Annuals > 3 > balance Sheet > payables
4178000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
12338000
Annuals > 3 > balance Sheet > equity
151664000
Annuals > 3 > cash Flow > net Income
-93036000
Annuals > 3 > cash Flow > depreciation
2616000
Annuals > 3 > cash Flow > change In Working Capital
1880000
Annuals > 3 > cash Flow > cash From Operations
-45824000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-297000
Annuals > 3 > cash Flow > cash From Financing
98824000
Annuals > 3 > cash Flow > net Change In Cash
53445000
Annuals > 3 > ratios > PE
-3.3983167600434276
Annuals > 3 > ratios > PB
2.2130699281306043
Annuals > 3 > ratios > ROE
-61.34349614938285
Annuals > 3 > ratios > ROA
-56.72857648077463
Annuals > 3 > ratios > FCF
-45824000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.7831937576063466
Valuation > metrics > PB
8.516473951728996
Valuation > final Score
20
Valuation > verdict
183.9% Overvalued
Profitability > metrics > ROE
-51.50617170510582
Profitability > metrics > ROA
-31.16313331603721
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8141137553983276
Risk > metrics > Interest Coverage
-35.8469387755102
Risk > final Score
-95
Risk > verdict
High
Liquidity > metrics > Current Ratio
26.605201528411193
Liquidity > metrics > Quick Ratio
26.605201528411193
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20.38552226806905
Prev Valuations > 1
29.380428716013032
Prev Valuations > 2
34.983292468771744
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-10
Prev Risks > 1
-154
Prev Risks > 2
-138
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:45:00.866Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.5233
Earnings History > 0 > eps Difference
0.5233
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.78
Earnings History > 1 > eps Estimate
-0.5
Earnings History > 1 > eps Difference
-0.28
Earnings History > 1 > surprise Percent
-56
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-31
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.5
Earnings History > 2 > eps Estimate
-0.37
Earnings History > 2 > eps Difference
-0.13
Earnings History > 2 > surprise Percent
-35.1351
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.35
Earnings History > 3 > eps Estimate
-0.53
Earnings History > 3 > eps Difference
0.18
Earnings History > 3 > surprise Percent
33.9623
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.41
Earnings History > 4 > eps Estimate
-0.2786
Earnings History > 4 > eps Difference
-0.1314
Earnings History > 4 > surprise Percent
-47.1644
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.27
Earnings History > 5 > eps Estimate
-0.28
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
3.5714
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.26
Earnings History > 6 > eps Estimate
-0.33
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
21.2121
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.14
Earnings History > 7 > eps Estimate
-0.53
Earnings History > 7 > eps Difference
-0.61
Earnings History > 7 > surprise Percent
-115.0943
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.59
Earnings History > 8 > eps Estimate
-0.46
Earnings History > 8 > eps Difference
-0.13
Earnings History > 8 > surprise Percent
-28.2609
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-02
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.45
Earnings History > 9 > eps Estimate
-0.67
Earnings History > 9 > eps Difference
0.22
Earnings History > 9 > surprise Percent
32.8358
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.76
Earnings History > 10 > eps Estimate
-0.54
Earnings History > 10 > eps Difference
-0.22
Earnings History > 10 > surprise Percent
-40.7407
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-04
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.52
Earnings History > 11 > eps Estimate
-0.42
Earnings History > 11 > eps Difference
-0.1
Earnings History > 11 > surprise Percent
-23.8095
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.16
Earnings History > 12 > eps Estimate
-0.5
Earnings History > 12 > eps Difference
0.34
Earnings History > 12 > surprise Percent
68
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.56
Earnings History > 13 > eps Estimate
-0.6
Earnings History > 13 > eps Difference
0.04
Earnings History > 13 > surprise Percent
6.6667
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.6
Earnings History > 14 > eps Estimate
-0.75
Earnings History > 14 > eps Difference
0.15
Earnings History > 14 > surprise Percent
20
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-16
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.6
Earnings History > 15 > eps Estimate
-0.75
Earnings History > 15 > eps Difference
0.15
Earnings History > 15 > surprise Percent
20
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.75
Earnings History > 16 > eps Estimate
-0.7
Earnings History > 16 > eps Difference
-0.05
Earnings History > 16 > surprise Percent
-7.1429
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-12
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.9
Earnings History > 17 > eps Estimate
-0.52
Earnings History > 17 > eps Difference
-0.38
Earnings History > 17 > surprise Percent
-73.0769
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-12
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.35
Earnings History > 18 > eps Estimate
-0.6
Earnings History > 18 > eps Difference
-0.75
Earnings History > 18 > surprise Percent
-125
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-14
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.04
Earnings History > 19 > eps Estimate
-0.23
Earnings History > 19 > eps Difference
0.19
Earnings History > 19 > surprise Percent
82.6087
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-30
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.15
Earnings History > 20 > eps Estimate
-0.3
Earnings History > 20 > eps Difference
0.15
Earnings History > 20 > surprise Percent
50
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-13
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.45
Earnings History > 21 > eps Estimate
-0.45
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-13
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.03
Earnings History > 22 > eps Estimate
-0.3
Earnings History > 22 > eps Difference
0.27
Earnings History > 22 > surprise Percent
90
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-14
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.03
Earnings History > 23 > eps Estimate
-0.45
Earnings History > 23 > eps Difference
0.42
Earnings History > 23 > surprise Percent
93.3333
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-08-31
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.6172
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-05-31
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.4129
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2019-02-28
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.472
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-09-30
Earnings History > 27 > report Date
2018-11-30
Earnings History > 27 > date
2018-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.3589
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-06-30
Earnings History > 28 > report Date
2018-08-31
Earnings History > 28 > date
2018-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.6171
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-03-31
Earnings History > 29 > report Date
2018-05-31
Earnings History > 29 > date
2018-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-1.5139
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2017-12-31
Earnings History > 30 > report Date
2018-02-28
Earnings History > 30 > date
2017-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.7814
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-09-30
Earnings History > 31 > report Date
2017-11-30
Earnings History > 31 > date
2017-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.5335
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-06-30
Earnings History > 32 > report Date
2017-08-31
Earnings History > 32 > date
2017-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-1.6671
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-03-31
Earnings History > 33 > report Date
2017-05-31
Earnings History > 33 > date
2017-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-1.7497
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2016-12-31
Earnings History > 34 > report Date
2017-02-28
Earnings History > 34 > date
2016-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-1.3518
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2016-09-30
Earnings History > 35 > report Date
2016-11-30
Earnings History > 35 > date
2016-09-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-2.0463
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMindMed Secures $259 Million in Public Offering to Advance Brain Health Innovations MSN
Read more →CEO Change: Is MNMD stock recession proof - July 2025 PreEarnings & AI Forecast Swing Trade Picks moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$25.6364
Analyst Picks
Strong Buy
7
Buy
4
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 58.78% of the total shares of Mind Medicine Inc
1.
BlackRock Inc(7.6256%)
since
2025/06/30
2.
COMMODORE CAPITAL LP(6.5713%)
since
2025/06/30
3.
Blackstone Inc(4.7149%)
since
2025/06/30
4.
Marshall Wace Asset Management Ltd(4.4964%)
since
2025/06/30
5.
Driehaus Capital Management LLC(4.0646%)
since
2025/06/30
6.
Deep Track Capital, LP(3.2857%)
since
2025/06/30
7.
Octagon Capital Advisors LP(2.7994%)
since
2025/06/30
8.
iShares Russell 2000 ETF(2.4077%)
since
2025/08/31
9.
Vanguard Group Inc(2.3841%)
since
2025/06/30
10.
State Street Corp(2.3734%)
since
2025/06/30
11.
Geode Capital Management, LLC(2.2782%)
since
2025/06/30
12.
Awm Investment Company Inc(1.5977%)
since
2025/06/30
13.
Fidelity Small Cap Index(0.9957%)
since
2025/06/30
14.
Vanguard Institutional Extnd Mkt Idx Tr(0.9656%)
since
2025/07/31
15.
Ally Bridge Group (NY) LLC(0.9544%)
since
2025/06/30
16.
Heptagon Driehaus US Micro Cap Eq C$ Acc(0.9236%)
since
2025/07/31
17.
Morgan Stanley - Brokerage Accounts(0.9049%)
since
2025/06/30
18.
TANG CAPITAL MANAGEMENT LLC(0.7888%)
since
2025/06/30
19.
Northern Trust Corp(0.7876%)
since
2025/06/30
20.
Charles Schwab Investment Management Inc(0.7862%)
since
2025/06/30
21.
UBS Group AG(0.6761%)
since
2025/06/30
22.
Woodline Partners LP(0.66%)
since
2025/06/30
23.
iShares Russell 2000 Value ETF(0.6062%)
since
2025/08/31
24.
Rosalind Advisors, Inc.(0.552%)
since
2025/06/30
25.
Fidelity Extended Market Index(0.4857%)
since
2025/07/31
26.
Vanguard Russell 2000 ETF(0.4719%)
since
2025/07/31
27.
Schwab US Small-Cap ETF™(0.4296%)
since
2025/08/30
28.
Driehaus Micro Cap Growth USD(0.3632%)
since
2025/07/31
29.
State St Russell Sm Cap® Indx SL Cl I(0.3541%)
since
2025/08/31
30.
Wellington Management Company LLP(0.3443%)
since
2025/06/30
31.
iShares Russell 2000 Growth ETF(0.2769%)
since
2025/08/31
32.
SPDR® S&P Pharmaceuticals ETF(0.2762%)
since
2025/08/31
33.
Schwab Small Cap Index(0.2527%)
since
2025/07/31
34.
Vanguard Health Care ETF(0.2449%)
since
2025/07/31
35.
iShares US Pharmaceuticals ETF(0.2403%)
since
2025/08/31
36.
NT R2000 Index Fund - NL(0.2396%)
since
2025/06/30
37.
iShares Micro-Cap ETF(0.2244%)
since
2025/08/31
38.
NT R2000 Index Fund - DC - NL - 3(0.191%)
since
2025/06/30
39.
Extended Equity Market Fund K(0.1813%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.5233
Date
2025-09-30
EPS Actual
-0.78
EPS Estimate
-0.5
EPS Difference
-0.28
Surprise Percent
-56%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.